Fifty pharmaceutical manufacturing facilities have shuttered their operations in Baddi, Himachal Pradesh, Asia’s largest pharmaceutical hub, while others are operating at significantly reduced capacities after the region was declared a containment zone, raising concerns about the shortage of supply of medicines in the country.
Chinese manufacturers and sellers of drug ingredients say logistical hurdles and labor shortages due to the coronavirus epidemic are delaying some production and shipments, adding to concerns about the potential for drug shortages globally as the virus spreads.
The government has advised the local active pharmaceutical ingredient (API) manufacturers not to export the essential products until import of the basic raw materials for medicines resumed fully from the coronavirus-hit China and India.
The coronavirus is rapidly spreading around the world, threatening to become a global pandemic. At the time of writing, nearly 95,000 people have been infected across 77 countries, while more than 3,200 people have died. While this human toll is undoubtedly the most tragic cost of the disease, the looming economic costs are also beginning to draw attention from policymakers, companies, and investors.
China’s efforts to contain the coronavirus by initially shutting down factories and keeping workforces at home could have global ramifications for public health around the world, including regarding diabetes, blood pressure, headaches and fevers.
The spreading coronavirus may soon affect people’s health in a different way: The outbreak is now starting to hurt the supply of essential drugs. Drug makers are struggling to get vital raw ingredients for common antibiotics and vitamins from Chinese factories, which were closed for weeks as China battled to contain the coronavirus. Now, even as some of the country’s factories have restarted, shortages of some drugs may develop.
India, the world’s main supplier of generic drugs, has restricted the export of 26 pharmaceutical ingredients and the medicines made from them, including Paracetamol, a common pain reliever also sold as acetaminophen, as the coronavirus outbreak plays havoc with supply chains.
The hospital waiting room was filled with dozens of women wearing homemade hazmat suits. Their hair was tucked tightly under shower caps. Their rain ponchos zipped taut over winter coats. All of the women, anxious and pregnant during the coronavirus outbreak, had been waiting hours to see the same doctor.
New Delhi: Pharmaceutical companies that market medicines made by third parties in the country will now be held responsible for drug product quality with the health and family welfare ministry on Thursday issuing a notification to this effect. The move will impact many big domestic and multinational pharmaceutical companies that get their medicines manufactured by smaller companies.